Essential Tremor: Diagnosis and Management

Introduction

Essential tremor (ET) is the commonest movement disorder², considerably more prevalent than Parkinson's disease, and causes a bilateral, largely symmetric postural and kinetic (action) tremor most often affecting the hands and forearms.¹ It can occur at any age but incidence rises with age, and a family history is common.

The central exam skill here is distinguishing ET from a Parkinsonian rest tremor, since the two are frequently confused by patients and, if the history is taken carelessly, by clinicians too. Getting this distinction right changes both the explanation given to the patient and the treatment offered.

Prevalence rises steeply with age, affecting perhaps 4-5% of people over 65, and a substantial proportion of those affected never seek medical attention because symptoms are mild or are assumed to be a normal part of ageing. This matters clinically: patients frequently present only once the tremor has begun to interfere with a specific valued activity, and the presenting complaint is often functional or social embarrassment rather than the tremor itself.

Aetiology

The precise pathophysiology remains incompletely understood, though cerebellar and cerebello-thalamo-cortical circuit dysfunction is implicated, rather than the basal ganglia dopaminergic pathway affected in Parkinson's disease. Current thinking centres on abnormal oscillatory activity within the loop connecting the cerebellum, the inferior olive, the thalamus and the motor cortex, with the ventral intermediate nucleus of the thalamus acting as a key relay - which is precisely why that nucleus is the target for both deep brain stimulation and focused ultrasound thalamotomy in refractory disease.

Post-mortem studies have found cerebellar changes, including Purkinje cell loss, in some cases, prompting debate about whether essential tremor is a purely functional oscillatory disorder or a mild neurodegenerative one. This is more than academic: it underpins ongoing investigation of whether long-standing essential tremor carries a modestly increased risk of later cognitive impairment, and it is why the condition is now often described as a family of related disorders rather than a single entity.

• Genetic predisposition - a family history is present in a large proportion of cases, often with an autosomal dominant pattern, though no single causative gene explains most cases
• Age - prevalence increases substantially with age, though onset can occur at any point from childhood to late adulthood
• No clear environmental trigger has been consistently identified, unlike some parkinsonian syndromes

Clinical features

• Postural tremor - present when the arms are held outstretched against gravity
• Kinetic (action) tremor - present and often worsened during voluntary movement, such as reaching for an object or writing, which particularly affects fine tasks like eating and drinking
• Bilateral and roughly symmetric, though one side may be more affected
• Frequency typically 4-12 Hz, finer than a typical Parkinsonian rest tremor³
• Improves, or is absent, at rest - the key distinguishing feature from Parkinson's disease
• Can involve the head (a 'yes-yes' or 'no-no' titubation), voice (a quavering quality), and less commonly the legs, particularly with longer disease duration
• Characteristically improves temporarily with a small amount of alcohol, and worsens with anxiety, caffeine, fatigue and stress - useful and often volunteered historical clues
• Slowly progressive over years to decades, gradually increasing in amplitude and functional impact rather than in new body regions alone

Clinical examination

• Observe tremor at rest - should be minimal or absent in ET
• Observe with arms outstretched (posture) - tremor typically present and visible
• Finger-to-nose testing (action) - tremor typically worsens as the finger approaches the target (unlike the more consistent, non-intention cerebellar-type pattern seen in some other conditions, though ET can itself have an intention component)
• Assess handwriting and spiral drawing - tremor is visible in the writing and drawn spirals, useful for both diagnosis and monitoring severity over time
• Assess head and voice for tremor involvement
• Full neurological examination should otherwise be normal - normal tone, no bradykinesia, no gait disturbance - which helps exclude Parkinson's disease and other causes
• Ask specifically about alcohol response and family history

Differential diagnosis

• Thyrotoxicosis - check thyroid function if there are other supportive features (weight loss, tachycardia, heat intolerance)
• Wilson's disease - consider in younger patients with tremor, especially with liver disease or a movement disorder combining features atypical for ET

Investigations

Essential tremor is a clinical diagnosis and no laboratory or imaging test confirms it. Investigations are used selectively to exclude alternative causes when the history or examination raises doubt.

Because there is no confirmatory test, the diagnosis rests on a carefully taken history and, importantly, on duration and stability. Essential tremor is typically present for years and changes very slowly. A tremor of recent onset that has progressed over months, or one accompanied by any additional neurological sign, does not fit the pattern and warrants investigation rather than a presumptive diagnosis.

Reviewing the patient over time is therefore a legitimate diagnostic strategy in itself. Where the picture is ambiguous, re-examining after six to twelve months frequently resolves it, as a parkinsonian syndrome will have declared itself with bradykinesia and rigidity while essential tremor will look essentially unchanged.

A functional assessment is worth incorporating at each review, since it is the impact rather than the amplitude that determines whether treatment is needed. Asking specifically about drinking from a full cup, eating soup, writing a signature, using a keyboard and managing buttons or shoelaces gives a far more useful picture than a subjective rating of severity, and provides a practical baseline against which to judge treatment.

• Thyroid function tests - if hyperthyroidism is a plausible contributor
• Medication review - to identify a drug-induced tremor (valproate, lithium, beta-agonists, amiodarone, some antidepressants)
• DaTscan - reserved for cases where distinguishing ET from Parkinson's disease or another parkinsonian syndrome remains genuinely unclear after full clinical assessment; normal in ET and reduced in Parkinson's disease and other synucleinopathies
• Caeruloplasmin/copper studies - if Wilson's disease is a plausible differential in a younger patient

Management

Treatment is offered when tremor causes functional impairment or embarrassment, not simply because it is present - many patients with mild ET need no drug treatment at all, just reassurance and an explanation of the diagnosis. That explanation matters in itself: many patients present having quietly feared they are developing Parkinson's disease, and being told clearly that this is a different, benign and non-progressive-to-parkinsonism condition is often the most valuable part of the consultation.

Practical measures should be discussed alongside any drug treatment, since they are often more useful than medication for mild disease: weighted cutlery and pens, wide-based cups filled only part-way, drinking through a straw, stabilising the elbows on a surface when performing fine tasks, and reducing caffeine and managing stress and fatigue, all of which exacerbate the tremor.

First-line drug treatment

Either can be used first-line, and the choice is often guided by comorbidities - propranolol is avoided in significant asthma or bradycardia, while primidone's initial sedating effect may be less acceptable for some patients. Combining the two is an option if a single agent gives only partial control.

Second-line and refractory treatment

• Topiramate, gabapentin or benzodiazepines - second-line options with variable evidence, used when first-line drugs are ineffective or not tolerated
• Botulinum toxin injections - can help focal, particularly hand or voice, tremor not controlled by oral medication
• Deep brain stimulation (typically of the ventral intermediate nucleus of the thalamus) - for severe, disabling tremor refractory to medical treatment
• MR-guided focused ultrasound thalamotomy - a newer, incisionless option creating a precise lesion in the same target, avoiding an implanted device

Complications

• Functional impairment - difficulty with eating, drinking, writing, and fine tasks, which can significantly affect independence and employment
• Social embarrassment and anxiety, particularly with visible hand or head tremor and voice involvement
• Progression to involve additional body regions and increasing amplitude over years
• Side effects of treatment - fatigue and bradycardia with propranolol, sedation and unsteadiness with primidone
• A modestly increased risk of later cognitive impairment has been described in some studies, though this remains an area of ongoing research rather than an established complication to counsel every patient on

Red flags

Essential tremor is a clinical diagnosis with no confirmatory test, so the safeguard against misdiagnosis is recognising when the picture does not fit. Any of the following should prompt a reappraisal rather than a trial of propranolol.

Prognosis

Essential tremor is typically slowly progressive over decades, gradually increasing in amplitude and sometimes spreading to involve the head, voice or legs in addition to the hands. It is not associated with reduced life expectancy, but functional and social impact can be considerable in more severe or advanced cases. Symptomatic treatment - medical or, for refractory severe tremor, surgical - can meaningfully improve function and quality of life, though it does not alter the underlying course of the condition.

Response to treatment is variable and often partial: propranolol and primidone each produce a clinically useful reduction in tremor amplitude in roughly half of patients, and a proportion lose benefit over time or cannot tolerate the doses required. Patients should be counselled that the realistic aim is to reduce tremor enough to restore specific functions - holding a cup, signing a name, eating in public - rather than to abolish it entirely. For those with severe, genuinely disabling tremor refractory to medication, deep brain stimulation and focused ultrasound thalamotomy can produce substantial and durable improvement, and referral should be considered rather than accepting persistent disability as inevitable.

Long-term follow-up is usually straightforward and can be delivered in primary care once the diagnosis is secure and treatment established, with referral reserved for diagnostic uncertainty, loss of treatment response, or consideration of a procedural option.

Finally, it is worth being clear about what essential tremor is not. It does not progress to Parkinson's disease, it does not shorten life, and the great majority of patients never require surgery. Framing the condition accurately at diagnosis - a common, benign, slowly progressive disorder with several effective symptomatic options - relieves a great deal of unnecessary anxiety, and is a legitimate and valuable therapeutic intervention in its own right.